BPC-157 + TB-500 Blend (Wolverine)
$100.00
Product Highlights
- CAS #:
BPC-157: 137525-51-0
TB-500: 885340-08-9 - Compound type:
BPC-157: Synthetic peptide
TB-500: Synthetic acetylated peptide fragment - Amino acid length:
BPC-157: 15 amino acids
TB-500: 7 amino acids - Amino acid sequence:
BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
TB-500: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln - Molecular formula:
BPC-157: C₆₂H₉₈N₁₆O₂₂
TB-500: C₃₈H₆₈N₁₀O₁₄ - Appearance: White to Off-White Lyophilized Powder
- Molecular weight:
BPC-157: 1419.5 g/mol
TB-500: Approximately 889.02 g/mol - Storage: Keep refrigerated after reconstitution.
For research use only
Product Description
BPC-157 + TB-500 Blend combines two synthetic research peptides used in experimental models involving cell migration, vascular signaling, cytoskeletal activity, and tissue-response pathways. BPC-157 is a 15-amino-acid peptide, while TB-500 is identified by the FDA’s substance registry as the N-terminally acetylated 17–23 fragment of thymosin beta-4, with the sequence Ac-LKKTETQ.
Research involving BPC-157 has examined its effects on endothelial-cell migration, nitric-oxide production, and Src–caveolin-1–eNOS signaling in cell and isolated-tissue models. Thymosin beta-4 research is associated with actin binding, cytoskeletal organization, and cellular-migration processes; however, findings involving the full thymosin beta-4 protein should not automatically be attributed to its shorter TB-500 fragment. The combined formulation is therefore best positioned for controlled laboratory studies comparing or jointly evaluating these distinct peptide-associated pathways rather than claiming a proven synergistic effect.
ATTENTION: All Unique ChemX products featured here are intended exclusively for research and development purposes. They are not designed for any form of human or animal consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.
